Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Xtant Medical Holdings, Inc.XTNT · Entity 7196 | VP & Chief Operations Officer | January 15, 2019 | January 16, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Xtant Medical Holdings, Inc.
Report date January 15, 2019 · Filed January 16, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.24 · Expires 2029-01-15 | Direct | 100,000 |
Reported balance
After 2019-01-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-15 · Grant · Acquired 100,000 · Balance 100,000 F1: This option vests with respect to 25,000 shares on each of January 15, 2020, January 15, 2021, January 15, 2022 and January 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. |
| Common Stock, $0.000001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2019-01-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests with respect to 25,000 shares on each of January 15, 2020, January 15, 2021, January 15, 2022 and January 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2019 Filed Jan 16, 2019 16:14 UTC | Xtant Medical Holdings, Inc. XTNT · Entity 7196 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001235802-19-000008 · primary_doc.xml · derivative · entry 2 Berlin Ronald G. · CIK 0001764230 · VP & Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2029-01-15 F1 · derivative.exercise_date: This option vests with respect to 25,000 shares on each of January 15, 2020, January 15, 2021, January 15, 2022 and January 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.